ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/10 | 1,503 | 1,530 | 1,496 | 1,503 | -40 | -2.6% | 653,500 |
| 2022/11/09 | 1,584 | 1,584 | 1,542 | 1,543 | -24 | -1.5% | 505,900 |
| 2022/11/08 | 1,558 | 1,584 | 1,554 | 1,567 | +26 | +1.7% | 672,900 |
| 2022/11/07 | 1,526 | 1,549 | 1,500 | 1,541 | +13 | +0.9% | 579,300 |
| 2022/11/04 | 1,544 | 1,544 | 1,504 | 1,528 | -38 | -2.4% | 703,600 |
| 2022/11/02 | 1,610 | 1,624 | 1,565 | 1,566 | -39 | -2.4% | 750,400 |
| 2022/11/01 | 1,640 | 1,640 | 1,599 | 1,605 | -28 | -1.7% | 465,500 |
| 2022/10/31 | 1,625 | 1,643 | 1,616 | 1,633 | +13 | +0.8% | 496,400 |
| 2022/10/28 | 1,597 | 1,623 | 1,593 | 1,620 | -9 | -0.6% | 1,104,500 |
| 2022/10/27 | 1,644 | 1,647 | 1,616 | 1,629 | ±0 | ±0% | 430,600 |
| 2022/10/26 | 1,594 | 1,649 | 1,594 | 1,629 | +75 | +4.8% | 904,400 |
| 2022/10/25 | 1,589 | 1,593 | 1,554 | 1,554 | -27 | -1.7% | 608,300 |
| 2022/10/24 | 1,620 | 1,621 | 1,567 | 1,581 | +1 | +0.1% | 559,800 |
| 2022/10/21 | 1,599 | 1,611 | 1,575 | 1,580 | -27 | -1.7% | 597,300 |
| 2022/10/20 | 1,611 | 1,625 | 1,600 | 1,607 | -44 | -2.7% | 782,500 |
| 2022/10/19 | 1,671 | 1,696 | 1,651 | 1,651 | -27 | -1.6% | 501,000 |
| 2022/10/18 | 1,690 | 1,717 | 1,667 | 1,678 | +48 | +2.9% | 806,300 |
| 2022/10/17 | 1,663 | 1,663 | 1,603 | 1,630 | -67 | -3.9% | 942,900 |
| 2022/10/14 | 1,690 | 1,726 | 1,674 | 1,697 | +33 | +2% | 812,800 |
| 2022/10/13 | 1,698 | 1,713 | 1,647 | 1,664 | -22 | -1.3% | 592,100 |
| 2022/10/12 | 1,699 | 1,732 | 1,678 | 1,686 | -37 | -2.1% | 592,000 |
| 2022/10/11 | 1,726 | 1,756 | 1,708 | 1,723 | -43 | -2.4% | 712,700 |
| 2022/10/07 | 1,746 | 1,811 | 1,741 | 1,766 | -5 | -0.3% | 986,100 |
| 2022/10/06 | 1,700 | 1,782 | 1,692 | 1,771 | +49 | +2.8% | 1,104,500 |
| 2022/10/05 | 1,758 | 1,778 | 1,701 | 1,722 | ±0 | ±0% | 805,600 |
| 2022/10/04 | 1,699 | 1,722 | 1,674 | 1,722 | +39 | +2.3% | 834,000 |
| 2022/10/03 | 1,606 | 1,683 | 1,567 | 1,683 | +68 | +4.2% | 719,100 |
| 2022/09/30 | 1,611 | 1,667 | 1,603 | 1,615 | -21 | -1.3% | 891,600 |
| 2022/09/29 | 1,596 | 1,645 | 1,569 | 1,636 | +110 | +7.2% | 1,035,600 |
| 2022/09/28 | 1,559 | 1,599 | 1,508 | 1,526 | -35 | -2.2% | 787,700 |
| 2022/09/27 | 1,596 | 1,626 | 1,552 | 1,561 | -45 | -2.8% | 604,700 |
| 2022/09/26 | 1,564 | 1,620 | 1,527 | 1,606 | -27 | -1.7% | 1,145,800 |
| 2022/09/22 | 1,600 | 1,649 | 1,586 | 1,633 | ±0 | ±0% | 583,400 |
| 2022/09/21 | 1,609 | 1,638 | 1,600 | 1,633 | +2 | +0.1% | 547,600 |
| 2022/09/20 | 1,689 | 1,689 | 1,602 | 1,631 | -53 | -3.1% | 781,500 |
| 2022/09/16 | 1,688 | 1,698 | 1,669 | 1,684 | -4 | -0.2% | 782,300 |
| 2022/09/15 | 1,691 | 1,703 | 1,663 | 1,688 | +55 | +3.4% | 750,500 |
| 2022/09/14 | 1,588 | 1,650 | 1,567 | 1,633 | -58 | -3.4% | 971,200 |
| 2022/09/13 | 1,700 | 1,711 | 1,684 | 1,691 | -10 | -0.6% | 417,700 |
| 2022/09/12 | 1,700 | 1,707 | 1,669 | 1,701 | +20 | +1.2% | 624,100 |
| 2022/09/09 | 1,672 | 1,689 | 1,661 | 1,681 | +40 | +2.4% | 823,000 |
| 2022/09/08 | 1,625 | 1,659 | 1,621 | 1,641 | +63 | +4% | 906,700 |
| 2022/09/07 | 1,608 | 1,613 | 1,554 | 1,578 | -36 | -2.2% | 737,600 |
| 2022/09/06 | 1,552 | 1,616 | 1,552 | 1,614 | +62 | +4% | 610,500 |
| 2022/09/05 | 1,546 | 1,567 | 1,523 | 1,552 | -11 | -0.7% | 722,100 |
| 2022/09/02 | 1,623 | 1,633 | 1,558 | 1,563 | -49 | -3% | 1,124,600 |
| 2022/09/01 | 1,637 | 1,640 | 1,612 | 1,612 | -69 | -4.1% | 806,800 |
| 2022/08/31 | 1,645 | 1,687 | 1,627 | 1,681 | +28 | +1.7% | 654,500 |
| 2022/08/30 | 1,625 | 1,659 | 1,618 | 1,653 | +16 | +1% | 695,300 |
| 2022/08/29 | 1,670 | 1,702 | 1,636 | 1,637 | -109 | -6.2% | 1,068,800 |
651～
700
件表示中 / 2951件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 152,900円 | +5.0% | +1.5% | 0.00% | 13.08倍 | 3.48倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 309,000円 | +8.0% | -15.3% | 4.01% | 8.67倍 | 0.84倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 180,500円 | +5.9% | +684.6% | 3.05% | 11.98倍 | 1.20倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 398,500円 | +3.6% | +6.1% | 3.01% | 13.42倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
市場注目の銘柄
チャート関連のコラム
